Fundraising FoxSolarea Bio
Waltham, US · Founded 2017 · Delaware corporation · 10 known investors
Find your way into Solarea Bio
Sign up to see every warm intro you have to Solarea Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Solarea Bio team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Solarea Bio develops plant-sourced living synbiotics (probiotics plus prebiotics) as medical foods targeting inflammatory conditions, starting with bone loss in women with osteopenia. Its clinically tested products aim to address underserved conditions such as osteopenia and rheumatoid arthritis.
Founders & leadership
Board
Investors · 10
How we know: joyancepartners.com · Not right? Tell us
How we know: Olive Tree Capital's portfolio page · Not right? Tell us
How we know: a partner's Signal profile · board seat on SEC Form D · funding news · prnewswire.com · Not right? Tell us
How we know: board seat on SEC Form D · Not right? Tell us
How we know: prnewswire.com · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
How we know: prnewswire.com · Not right? Tell us
Also in the syndicate · 1
Reported raises · per SEC filings
Form D private placements$37.2M disclosed across 4 rounds · 2020–2025
▶$9.9MraisedNov 2025 · 5 investors · BiotechnologyRule 506(b)
- NEAL BHADKAMKARDirector
- MATTHEW WALKERDirector
- ANULA JAYASURIYADirector
- GREGORY SIECZKIEWICZDirector
- CATHERINE BALSAM-SCHWABERExecutive Officer, Director
- ERIC SCHOTTExecutive Officer
- Amount sold
- $9.9M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedSep 2024 · 1 investors · BiotechnologyRule 506(b)
- ANULA JAYASURIYADirector
- MATTHEW WALKERDirector
- NEAL BHADKAMKARDirector
- ILISSA LARIMOREExecutive Officer
- GREGORY SIECZKIEWICZDirector
- GERARDO TOLEDOExecutive Officer, Director
- ERIC SCHOTTExecutive Officer
- Amount sold
- $1M
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MraisedMay 2023 · 4 investors · BiotechnologyRule 506(b)
- ANULA JAYASURIYADirector
- GREGORY SIECZKIEWICZDirector
- MATTHEW WALKERDirector
- GERARDO TOLEDOExecutive Officer, Director
- NEAL BHADKAMKARDirector
- ERIC SCHOTTExecutive Officer
- Offering amount
- $25M
- Amount sold
- $15M
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.3MraisedSep 2020 · 15 investors · BiotechnologyRule 506(b)
- GREGORY SIECZKIEWICZDirector
- GERARDO TOLEDOExecutive Officer, Director
- ERIC SCHOTTExecutive Officer
- MATTHEW WALKERDirector
- NEAL BHADKAMKARDirector
- ANULA JAYASURIYADirector
- Offering amount
- $14.8M
- Amount sold
- $11.3M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Solarea Bio do?
- Solarea Bio develops plant-sourced living synbiotics (probiotics plus prebiotics) as medical foods targeting inflammatory conditions, starting with bone loss in women with osteopenia. Its clinically tested products aim to address underserved conditions such as osteopenia and rheumatoid arthritis.
- Who are Solarea Bio's investors?
- Solarea Bio's investors include Joyance Partners, Olive Tree Capital, Rising Tide, Bold Capital Partners, DigitalDx Ventures, GISEV Family Office, S2G Investments, Viking Global and 1 more.
- How much funding has Solarea Bio raised?
- Solarea Bio has disclosed $37.2M raised across 4 rounds.
- Where is Solarea Bio headquartered?
- Solarea Bio is headquartered in Waltham, US.